Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letermovir for CMV Prophylaxis in Kidney and Liver Transplant Recipients
NCT07706166Phase 4Not yet recruiting
- Sponsor
- University of Wisconsin–Madison
- Start
- Oct 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
A Phase 4 trial of letermovir in cytomegalovirus infection (CMV), sponsored by University of Wisconsin–Madison. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
letermovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT07706166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07706166.